Breakthrough pregnancy test could spot diabetes risk earlier
NCT ID NCT06048510
Summary
This study aims to find better ways to predict which pregnant women will develop gestational diabetes and have babies with high birth weight (macrosomia). Researchers will test 800 pregnant women using new markers (skin autofluorescence and glycated albumin) and compare them to the standard blood test. The goal is to improve early detection and potentially prevent complications for both mother and baby.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES MELLITUS IN PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopital Pellegrin
RECRUITINGBordeaux, 33000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.